Axsome Therapeutics, Inc. Liquidation Value
AXSM
Other
Cash & Equivalents
$322.93M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $322.93M
Total Obligations: -$526.95M
$-204.02M
Per share: $-4.01
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $322.93M
AR: $224.46M
Total Obligations: -$526.95M
$20.45M
Per share: $0.40
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $322.93M
AR: $224.46M
Inventory: $27.94M
Total Obligations: -$526.95M
$48.39M
Per share: $0.95
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-204.02M | $-4.01 |
| Liquid Liquidation Value | $20.45M | $0.40 |
| Operating Liquidation Value | $48.39M | $0.95 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $322.93M |
| Accounts Receivable | $224.46M |
| Inventory | $27.94M |
| Current Liabilities | $378.84M |
| Long-term Debt | $117.75M |
| Op. Lease Liability | $23.62M |
| Finance Lease | $6.75M |
| Shares Outstanding | 50.9M |
Explore all 207 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $322.93M | $224.46M | $27.94M | $65.54M | $378.84M | $117.75M | $23.62M | $6.75M |
| 2025-09-30 | $325.27M | $196.51M | $23.77M | $54.23M | $360.29M | $117.64M | $23.78M | $7.18M |
| 2025-06-30 | $303.02M | $198.82M | $18.44M | $91.63M | $342.10M | $117.54M | $23.96M | $5.81M |
| 2025-03-31 | $300.91M | $161.40M | $16.32M | $85.66M | $243.91M | $181.38M | $24.36M | $5.50M |
▼ Community Notes